“CPUs are already prevalent in embedded devices, edge servers, data centers and cloud,” Prashant Shah, director of engineering at Intel Health and Life Sciences, told HCB News at the time. “By enabling deep learning workloads to run efficiently on CPUs, our customers don't need to add expensive accelerator cards to their solutions.”

Goldman Aslan says that Intel technology will enable more providers to adopt DiA's AI-based software in the Echo Lab without modifying or improving hospital hardware infrastructure to GPU VM systems and without having to compromise performance. "Offering our LVivo Seamless, an AI-based ultrasound cardiac software, with OpenVino allows hospitals to enjoy the benefits of AI systems with great clinical and financial value that otherwise they would not be able to achieve within their current infrastructure. It makes the echo lab workflow more efficient and makes key measurement results available to more qualified patients."


In addition to Intel, DiA recently partnered with Change Healthcare and will add its LVivo Seamless with Change’s imaging solutions in Echo Labs reading environment. The solution will generate key clinical indications of both left and right ventricle function that will appear on the CPACS viewer for review immediately. Change expects clinicians to be better able to perform routine tasks and perform cardiac ultrasound analysis under a more efficient workflow with the application.

Back to HCB News

Cardiology Homepage